Skip to main content

Europe

Article

Infographic: Building the European biotech sector with world-class talent

– What makes European biotech attractive? Talent is one reason. Europe ranks high in the level of innovation and the quality of... R&D talent, particularly for research, and the amount of available talent in drug development is increasing. For rare diseases and oncology, however, experienced people are considered to be in short supply. And while the challenges of attracting and retaining biotech talent (as well as talent for business development) are not unique to Europe, these will continue to be important for biotech’s growth in this market. Read more in “Biotech in Europe: A strong foundation for growth and innovation.”
Article

European private banking: An inescapable call for action

– New headwinds in a profitable market indicate the need for fundamental transformation.
Article

Infographic: Europe’s potential for biotech innovation

– Europe has world-class universities, research institutions, medical centers, and hospitals that provide a strong base for sourcing... and developing scientific innovation. However, this strength does not yet translate into patents for new medicines, as Europe trails both China and the United States in that area. Increased investment in biotech may hold the key to helping grow Europe’s share of new drugs. Europe’s biotechs currently receive only 20 percent of the funding their US counterparts do. Read more in “Biotech in Europe: A strong foundation for growth and innovation.”
Article

A perspective on German payments

– For German banks, payments are a key revenue source and a connection to customers. A changing market landscape could challenge... that position.
Article

Telecom operators: Surviving and thriving through the next downturn

– Telco operators are more vulnerable today than they were ten years ago. To thrive through the next economic downturn and beyond,... they must act now—and with focus.
Article

Infographic: Europe’s biotech hot spots

– Europe has a complex biotech landscape, with hundreds of companies, multiple paths to innovation and financing, and marked differences... among countries. To see through the complexity, we grouped approximately 1,000 European biotech companies into eight clusters based on country, modality, and therapeutic area. We identified biotech hot spots as well as trends and possible directions for the region. Read more in “Biotech in Europe: A strong foundation for growth and innovation.”
Article

Biotech in Europe: A strong foundation for growth and innovation

– European companies have an opportunity to play a stronger role in the industry by focusing on three factors.
Article

GDPR compliance since May 2018: A continuing challenge

– Companies must automate and streamline, or the challenge of GDPR compliance will overwhelm them.
Interview

Defining a public-cloud strategy: An interview with Michael Ørnø, of Denmark’s Statens IT

– Statens IT, the Danish government shared-service center for IT, has established a comprehensive government data center. The next... step is to embrace the opportunities and challenges of the public cloud.
Article

Education reform in Norway: Looking beyond politics to bring sustained change

– Education policy in Norway has been shaped by data more than by doctrine. As a result, education reforms in the country have been... supported by various governments across a broad political spectrum for more than a decade.
Article - McKinsey Quarterly

Confronting overconfidence in talent strategy, management, and development

– Best practices are well understood. But are companies following them as closely as their leaders claim?
Sorry, we couldn't find any results. Try removing some filters.